Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial. (2015)
Attributed to:
Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2015-007645
PubMed Identifier: 26253566
Publication URI: http://europepmc.org/abstract/MED/26253566
Type: Journal Article/Review
Volume: 5
Parent Publication: BMJ open
Issue: 8
ISSN: 2044-6055